글로벌 미생물학 테스트 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

미생물학 테스트 시장 분석

미생물 검사 시장은 감염성 질환의 유병률 증가, 신속한 진단 검사에 대한 수요 증가, 실험실 기술의 발전에 힘입어 상당한 성장을 경험하고 있습니다. 글로벌 의료 환경이 변화함에 따라 미생물 감염 의 조기 감지 및 모니터링에 대한 강조가 커지고 있으며, 이로 인해 미생물 검사 솔루션 에 대한 수요가 높아졌습니다 . 분자 진단 및 자동화의 최근 발전으로 검사의 정확성과 속도가 향상되어 시기적절한 환자 관리가 용이해지고 있습니다. 또한 COVID-19 팬데믹은 공중 보건에서 미생물 검사의 중요성을 강조하여 연구 개발에 대한 투자를 촉진했습니다. 의료 서비스 제공자가 환자 결과를 개선하기 위해 노력함에 따라 미생물 검사 시장은 혁신적인 제품과 감염 관리 조치에 대한 인식 증가에 힘입어 더욱 확대될 준비가 되었습니다. 기술 발전과 감염성 질환 관리에 대한 집중이 높아짐에 따라 시장은 향후 몇 년 동안 지속적인 성장을 이룰 수 있는 위치에 있습니다.

미생물학 테스트 시장 규모

글로벌 미생물학 테스트 시장 규모는 2023년에 50억 2천만 달러로 평가되었으며, 2031년까지 100억 9천만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 9.10%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

미생물학 테스트 시장 동향

“ 분자 진단의 혁신”

미생물학 검사 시장은 기술 발전과 감염병 관리에 대한 강조가 커지면서 혁신적인 추세를 보이고 있습니다. 중합효소 연쇄 반응(PCR) 및 차세대 시퀀싱(NGS)과 같은 분자 진단의 혁신은 미생물 식별의 속도와 정확성을 향상시키고 있습니다. 주목할 만한 추세 중 하나는 다양한 의료 환경에서 신속한 진단을 가능하게 하는 진료소 검사(POCT)의 채택이 증가하고 있어 시기적절한 치료 결정을 내리고 환자 결과를 개선할 수 있습니다. 분산형 검사로의 이러한 전환은 임상 워크플로의 효율성에 대한 필요성과 즉각적인 결과에 대한 수요에 의해 촉진됩니다. 이러한 추세가 시장을 계속 형성함에 따라 감염병이 제기하는 과제를 효과적으로 해결하기 위해 진단 기능을 향상시키는 데 중점을 두고 있습니다.

보고서 범위 및 미생물학 테스트 시장 세분화

Microbiology Testing Market Definition

Microbiology testing involves laboratory techniques to detect, identify, and quantify microorganisms such as bacteria, viruses, fungi, and parasites. It plays a crucial role in diagnosing infections, ensuring food and water safety, monitoring environmental health, and supporting medical research. Common methods include culture tests, molecular diagnostics (e.g., PCR), immunological assays, and microscopy, making it essential across healthcare, pharmaceuticals, and food industries.

Microbiology Testing Market Dynamics

Drivers

• Increasing Incidence of Fungal Infections

The increasing incidence of infectious diseases, such as bacterial, viral, and fungal infections, significantly drives the demand for microbiology testing. As populations grow and urbanization expands, the risk of outbreaks and the transmission of infectious agents rises, highlighting the critical need for timely and accurate diagnosis. Microbiology testing plays a vital role in identifying pathogens, determining their susceptibility to treatment, and guiding healthcare professionals in making informed decisions regarding patient care. This demand is further amplified by the emergence of new infectious diseases and antibiotic-resistant strains, necessitating robust testing methodologies. Consequently, healthcare facilities and laboratories are increasingly investing in advanced microbiology testing solutions to enhance patient outcomes, streamline treatment protocols, and effectively manage public health challenges. This trend underscores the importance of microbiology testing in modern healthcare settings.

• Rising Demand for Point-of-Care Testing

The shift towards point-of-care testing (POCT) is revolutionizing the microbiology testing market by enabling rapid diagnosis and treatment in various healthcare settings, particularly urgent care and emergency departments. POCT facilitates immediate access to diagnostic results, allowing healthcare professionals to make timely decisions regarding patient care. This is especially crucial in situations where prompt treatment is necessary to prevent complications or further spread of infections. The convenience of POCT reduces the need for patients to wait for laboratory results, enhancing the overall efficiency of healthcare delivery. Moreover, advancements in portable diagnostic technologies are making POCT more accessible in remote and resource-limited settings, thus broadening its adoption. As a result, the growing demand for rapid and efficient testing solutions is driving significant growth in the microbiology testing market.

Opportunities

• Emergence of Rapid Diagnostic Technologies

The microbiology testing market is witnessing significant opportunities due to the development of advanced molecular techniques, including polymerase chain reaction (PCR) and next-generation sequencing (NGS). These innovative technologies facilitate faster and more accurate detection of pathogens, which is crucial for the timely diagnosis and treatment of infectious diseases. As healthcare providers and laboratories increasingly prioritize rapid diagnostics to improve patient outcomes, the demand for these advanced testing methods continues to rise. Furthermore, the ability to analyze genetic material enables the identification of specific strains, assisting in the appropriate selection of antimicrobial therapies. Companies that invest in the development and implementation of these molecular techniques can create market opportunities and meet the growing needs of healthcare providers and patients alike.

• Expansion of Telehealth Services

The rising popularity of telehealth and remote patient monitoring is driving demand for at-home microbiology testing kits, creating a significant market opportunity. These kits offer patients the convenience of conducting tests in their own homes, allowing for timely diagnosis without the need to visit healthcare facilities. This shift enhances patient comfort and expands the reach of healthcare providers, enabling them to offer services to a broader patient base. As telehealth continues to gain traction, the integration of microbiology testing kits into these platforms can facilitate effective monitoring and management of infectious diseases. Companies that develop reliable and user-friendly at-home testing solutions can capitalize on this trend, improving patient access to essential diagnostic services while contributing to the overall efficiency of healthcare delivery.

Restraints/Challenges

• Sample Collection and Handling

Proper sample collection and handling are fundamental to ensuring accurate results in microbiology testing. Any contamination, improper storage, or mishandling of samples can significantly compromise the integrity of the results, leading to misdiagnosis and inappropriate treatment. Unfortunately, inadequate training of healthcare personnel often results in errors during the sample collection process. This lack of training can stem from insufficient educational programs or the high turnover rates within healthcare settings, which prevent staff from receiving consistent and thorough training. Consequently, errors in sample collection and handling affect the reliability of microbiology testing outcomes and lead to increased healthcare costs and adverse patient outcomes. Therefore, investing in comprehensive training programs for healthcare personnel is essential to mitigate these challenges and enhance the accuracy of microbiology testing.

•  High Costs of Advanced Technologies

The development and implementation of advanced microbiology testing technologies, including molecular diagnostics, often come with significant financial investment. These high initial costs can be a considerable barrier, particularly for smaller laboratories and healthcare facilities that may struggle to allocate sufficient budget for cutting-edge testing solutions. As a result, these entities may opt for traditional, less expensive testing methods, which can limit their ability to provide rapid and accurate diagnoses. Consequently, the high costs associated with adopting advanced microbiology testing technologies may hinder market growth by restricting access to innovative solutions in various healthcare settings. This financial challenge poses a restraint on the broader adoption and potential advancements within the microbiology testing market.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Microbiology Testing Market Scope

The market is segmented on the basis of test type, product, indication, application, and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Bacterial
• Viral
• Fungal

Product

• Instruments
• Reagents

Indication

• Respiratory Diseases
• Bloodstream Infections
• Gastrointestinal Diseases
• Sexually Transmitted Diseases
• Urinary Tract Infection
• Periodontal Diseases
• Others

Application

• Pharmaceutical Applications
• Food Testing Applications
• Clinical Applications
• Energy Applications
• Chemical and Material Manufacturing Applications
• Environmental Applications

End User

• Hospitals and Diagnostic Centers
• Custom Lab Service Providers
• Academic Institutions
• Research Institutes

Microbiology Testing Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, test type, product, indication, application, and end-users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the microbiology testing market, supported by a vast network of healthcare facilities and significant investments from key industry players in developing advanced testing devices. In addition, the region benefits from well-established distribution channels for clinical microbiology products and an increasing volume of research activities, all contributing to robust market growth. These factors combine to solidify North America's position as a dominant force in the microbiology testing sector.

Asia-Pacific is poised for substantial growth in the microbiology testing market, driven by increased government initiatives aimed at raising awareness and implementing favorable regulatory policies that promote the adoption of testing methods. In addition, the region is seeing a rise in the use of advanced diagnostic techniques and a growing demand for high-quality healthcare services. These factors collectively position Asia-Pacific as a rapidly evolving market for microbiology testing.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Microbiology Testing Market Share

시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 시장과 관련된 회사의 초점에만 관련이 있습니다.

시장에서 운영되는 미생물학 테스트 시장 리더는 다음과 같습니다.

• 메드트로닉(아일랜드)
• 마시모(미국)
• Koninklijke Philips NV(네덜란드)
• 제너럴 일렉트릭 회사(미국)
• 스트라이커(미국)
• iHealth Labs Inc. (미국)
• 시스코 시스템즈(미국)
• 실리콘 & 소프트웨어 시스템 유한회사(아일랜드)
• Spectrum Medical Devices(영국)
• 힐롬 서비스 주식회사(미국)
• Iatric Systems Inc. (미국)
• Silex Technology America, Inc. (일본)
• 디지 인터내셔널 주식회사 (미국)
• 백스터(미국)
• TE 커넥티비티(스위스)
• 메디컬렉터(미국)

미생물학 테스트 시장의 최신 동향

• 2022년 11월, IDEXX는 자동화된 수질 미생물 검사 솔루션으로 유명한 캐나다의 선도적 기업인 Tecta-PDS를 인수하여 시장 지위를 강화했습니다. 이 전략적 인수를 통해 IDEXX는 실험실 및 현장 검사 요구 사항을 모두 충족하는 수질 미생물 검사에서 제공하는 서비스를 개선할 수 있었습니다. 그 결과, IDEXX는 효율적이고 신뢰할 수 있는 수질 검사 솔루션에 대한 증가하는 수요를 충족할 수 있는 더 나은 장비를 갖추게 되었습니다.
• 2022년 11월, Archer Daniels Midland(ADM)는 일리노이주 디케이터에 있는 특수 제조 시설에 새로운 미생물학 실험실을 시작했습니다. 이 확장으로 실험실 규모가 크게 늘어나 미생물학 테스트에 할당된 공간이 사실상 두 배로 늘어났습니다. 그 결과, 시설의 테스트 역량이 크게 향상되어 ADM이 고객의 요구 사항을 더 잘 충족할 수 있는 위치에 서게 되었습니다.
• 2024년 1월, 베이징 기술 연구소(BIT)는 중국 우주 정거장에서 수행된 미생물학 연구에서 상당한 진전을 이루었다고 밝혔습니다. 최신 연구 프로젝트는 Mengtian 실험 모듈에 성공적으로 배치되었습니다. 이 이니셔티브는 미생물 행동과 성장에 대한 무중력의 영향을 탐구하여 이 분야에 귀중한 통찰력을 제공하는 것을 목표로 합니다.
• 2023년 1월, BD는 미생물학 연구실을 위해 특별히 설계된 완전 자동화된 로봇 트랙 시스템을 출시했습니다. 그 후, 2024년 2월, 모디 총리는 아삼에 17대의 식품 테스트 차량과 함께 새로운 미생물학 연구실을 개관했습니다. 이러한 이니셔티브는 연구실 효율성을 높이고 이 지역의 식품 안전 테스트 역량을 개선하는 것을 목표로 합니다.

SKU-25526